Entasis Therapeutics Ltd
We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria.
$16.00 - $18.00
Credit Suisse, BMO Capital Markets, SunTrust Robinson Humphrey, Wedbush PacGrow
To view the prospectus for Entasis Therapeutics Ltd IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277